Alternative Reliable Method for Cytochrome P450 2D6 Poor Metabolizers Genotyping

被引:0
|
作者
E. Pindurová
A. Žourková
J. Zrůstová
J. Juřica
A. Pavelka
机构
[1] Central European Institute of Technology (CEITEC),Department of Applied Neuroscience, Faculty of Medicine
[2] Masaryk University,Department of Psychiatry, Faculty of Medicine
[3] Faculty Hospital Brno-Bohunice,Department of Medical Genetics
[4] Faculty Hospital Brno,Department of Pharmacology, Faculty of Medicine
[5] Experimental and Applied Neuropsychopharmacology Group,Department of Experimental Biology, Faculty of Science
[6] Central European Institute of Technology (CEITEC),Department of Computer Graphics and Design, Faculty of Informatics
[7] Masaryk University Brno,undefined
[8] Masaryk University,undefined
[9] Masaryk University,undefined
来源
Molecular Biotechnology | 2013年 / 53卷
关键词
High-resolution melting analysis; CYP2D6; Poor metabolizers; SNP; Short amplicon; Melting curve;
D O I
暂无
中图分类号
学科分类号
摘要
High-resolution melting curve analysis (HRM) of polymerase chain reaction (PCR) amplicons has been described as a fast, cheap, and reliable closed-tube method of genotyping with no need for labeled primers or labeled probes. We adapted this melting analysis assay for the detection of the most common nonfunctional alleles of cytochrome P-450 (CYP) 2D6 in the Caucasian population that affect the metabolism of many commonly used drugs. We used this method to genotype 91 patients under paroxetine therapy. The presence and the constitution of the most common single-nucleotide polymorphisms (1846G>A, 2988G>A, 100C>T, 2549delA, 2615_2617delAAG, and 1707delT) in poor and intermediate metabolizers from the Caucasian population were detected in short amplicons (≤148 bp). After fluorescence normalization, the wild-type, homozygous, and heterozygous samples were easily distinguishable from each other by their specific melting curve shape. A total of 92.6% of the 1846G>A heterozygotes, 96% of the 100C>T heterozygotes, and 100% of the 2988G>A, 2549delA, 2615_2617delAAG, and 1707delT heterozygotes have been correctly distinguished from the wild types. One hundred percent of all the homozygotes in this group of patients have been detected without any error. HRM of short amplicons is a simple tool for effective, rapid, and reliable CYP2D6 genotyping that does not require real-time PCR, labeled probes, processing or any separations after PCR. The reaction is performed in a closed-tube system and is highly specific and sensitive. We proved that this technique is highly reliable for use in routine diagnostics.
引用
收藏
页码:29 / 40
页数:11
相关论文
共 50 条
  • [1] Alternative Reliable Method for Cytochrome P450 2D6 Poor Metabolizers Genotyping
    Pindurova, E.
    Zourkova, A.
    Zrustova, J.
    Jurica, J.
    Pavelka, A.
    MOLECULAR BIOTECHNOLOGY, 2013, 53 (01) : 29 - 40
  • [2] Rapid and reliable method for cytochrome P450 2D6 genotyping
    Stamer, UM
    Bayerer, B
    Wolf, S
    Hoeft, A
    Stüber, F
    CLINICAL CHEMISTRY, 2002, 48 (09) : 1412 - 1417
  • [3] Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers
    Wilner, KD
    Demattos, SB
    Anziano, RJ
    Apseloff, G
    Gerber, N
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 : 43S - 47S
  • [4] Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6
    Takahashi, Paul Y.
    Ryu, Euijung
    Pathak, Jyotishman
    Jenkins, Gregory D.
    Batzler, Anthony
    Hathcock, Matthew A.
    Black, John Logan
    Olson, Janet E.
    Cerhan, James R.
    Bielinski, Suzette J.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2017, 10 : 39 - 47
  • [5] Cytochrome P450 2D6
    Owen, Ryan P.
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (07): : 559 - 562
  • [6] Comparison of the Pharmacokinetics of Venlafaxine Extended Release and Desvenlafaxine in Extensive and Poor Cytochrome P450 2D6 Metabolizers
    Preskorn, Sheldon
    Patroneva, Albena
    Silman, Heather
    Jiang, Qin
    Isler, Jennifer A.
    Burczynski, Michael E.
    Ahmed, Saeeduddin
    Paul, Jeffrey
    Nichols, Alice I.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (01) : 39 - 43
  • [7] Tardive dyskinesia and cytochrome P450 2D6 genotyping in schizophrenia
    Lam, LCW
    Ungvari, GS
    Garcia, M
    Kwong, SL
    Chiu, HFK
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 261 - 261
  • [8] Cytochrome P450 2D6 genotyping of fatal intoxications using Pyrosequencing
    Zackrisson, AL
    Holmgren, P
    Gladh, AB
    Ahlner, J
    Lindblom, B
    PROGRESS IN FORENSIC GENETICS 10, 2004, 1261 : 36 - 38
  • [9] Allosteric effects of cytochrome P450 reductase on cytochrome P450 2D6
    Roberts, GCK
    Modi, S
    Gilham, DE
    Sutcliffe, MJ
    Lian, LY
    Primrose, WU
    Wolf, CR
    FASEB JOURNAL, 1997, 11 (09): : A789 - A789
  • [10] Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6)
    Desta, Z
    Kerbusch, T
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (01) : 10 - 20